Celonic ag Review

About Celonic ag

Celonic AG: Enabling the Next Generation of Breakthrough Biotherapeutics

Celonic AG is a global biologics Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and production of biotherapeutics. The company has a proven track record of delivering high-quality, cost-effective solutions to its clients, enabling them to bring their products to market faster and more efficiently.

Founded in 2006, Celonic AG has grown rapidly over the years, expanding its capabilities and expertise in biologics development and manufacturing. Today, the company operates state-of-the-art facilities in Switzerland and Germany, employing over 200 highly skilled professionals who are dedicated to delivering exceptional service to their clients.

At Celonic AG, we understand that developing biotherapeutics is a complex process that requires specialized knowledge and expertise. That's why we offer a comprehensive range of services that cover every stage of drug development – from discovery through clinical trials to commercialization.

Our services include cell line development, process optimization, analytical testing, formulation development, clinical trial supply management, commercial manufacturing and packaging. We also provide regulatory support throughout the entire drug development process.

One of our key strengths is our ability to work closely with our clients as true partners. We take pride in understanding their unique needs and challenges so that we can tailor our solutions accordingly. Our team works collaboratively with clients at every stage of drug development – from initial concept through final product launch – ensuring seamless integration between all stages.

At Celonic AG we are committed to quality excellence. Our facilities are fully compliant with cGMP regulations for both clinical trial materials as well as commercial products. We have implemented rigorous quality control systems throughout our operations which ensure consistent product quality while minimizing risk for patients.

We also recognize the importance of innovation in driving progress within the biopharmaceutical industry. That's why we invest heavily in research & development activities aimed at improving existing processes and developing new technologies that can help our clients bring their products to market faster and more efficiently.

In summary, Celonic AG is a leading biologics CDMO that provides end-to-end services for the development and production of biotherapeutics. Our team of experts is dedicated to delivering high-quality, cost-effective solutions that enable our clients to bring their products to market faster and more efficiently. We are committed to quality excellence, innovation, and partnership with our clients – all of which make us the ideal partner for companies looking to develop breakthrough biotherapeutics.